INOVIO PHARMACEUTICALS, INC.
INOVIO PHARMACEUTICALS, INC. is a federal contractor, registered under UEI CE2NDNHN33X5 and CAGE code 43MD0. It has been awarded $70,433,270 in federal contracts. Primary work spans Unknown NAICS, Research and Development in Biotechnology (except Nanobiotechnology), and Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). Top awarding agencies include Department Of Defense, Department Of Health And Human Services (hhs), and Other agencies (1 agencies, <0.5% each).
Contact Information
Registration and classification details
Registration
UEI Code
CE2NDNHN33X5CAGE Code
43MD0Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
INOVIO PHARMACEUTICALS, INC. specializes in the research, development, and clinical translation of DNA-based therapeutics and vaccines, with a focus on electroporation-enabled delivery platforms. The company’s core technical expertise lies in synthetic DNA design, plasmid manufacturing, and in vivo ...
INOVIO PHARMACEUTICALS, INC. specializes in the research, development, and clinical translation of DNA-based therapeutics and vaccines, with a focus on electroporation-enabled delivery platforms. The company’s core technical expertise lies in synthetic DNA design, plasmid manufacturing, and in vivo delivery systems utilizing proprietary electroporation devices to enhance cellular uptake of genetic material. Their work centers on immunotherapeutic applications for infectious diseases and oncology, integrating molecular biology, immunology, and biomedical engineering to advance novel vaccine candidates from preclinical proof-of-concept through human trials. Differentiators include their ability to rapidly design and scale DNA vaccine constructs, maintain cold-chain stability without refrigeration, and leverage non-viral delivery mechanisms to improve safety profiles over traditional viral vector platforms. Award history is not available to determine specific agency relationships or contracting patterns. Consequently, no definitive agency experience can be inferred from the provided data. The primary NAICS code 541714 indicates engagement in research and development in the life sciences, specifically in biotechnology, where the company operates at the intersection of genetic engineering and clinical product development. Their market positioning is that of a specialized biotech innovator focused on next-generation vaccine platforms, serving the U.S. government’s biodefense and public health preparedness interests through advanced therapeutic R&D. INOVIO PHARMACEUTICALS, INC. is structured as a publicly traded corporation headquartered in San Diego, California. The company does not hold any active federal certifications such as 8(a), HUBZone, or WOSB. Its government market presence is defined by its role as a non-traditional defense and health security contractor, leveraging proprietary biotechnological platforms to support federal research initiatives in infectious disease preparedness and medical countermeasure development.
Key Performance Metrics
Awards Count
18
All time
Active
0
Currently performing
Completed
18
Past period of performance
Total Awards
All time
Award Analytics & Distribution
Subsidiaries
1 company rolls up into INOVIO PHARMACEUTICALS, INC., sized by each one's own awards
Compete with INOVIO PHARMACEUTICALS, INC.
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for INOVIO PHARMACEUTICALS, INC.
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
